(Q44062327)

English

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

based on heuristic

inferred from title

Francisco J Esteva

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lavinia P Middleton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Gabriel N Hortobagyi

8

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Jianzhou Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Thomas A Buchholz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Craig Allred

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Susan L Tucker

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Henry M Kuerer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Aysegul A Sahin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

94

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

3107-3114

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115341%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Six-year results of a multimodality treatment strategy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

c-erbB-2 expression in benign and malignant breast disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

The hunt for Ras targets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Prediction of response to primary chemotherapy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

HER2/neu amplification and comedo type breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10585

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44062327&oldid=2106155045"